NO20031043D0 - Nye substituerte bifenylforbindelser, fremgangsmåte for deres fremstillingog farmasöytiske sammensetninger inneholdende dem - Google Patents
Nye substituerte bifenylforbindelser, fremgangsmåte for deres fremstillingog farmasöytiske sammensetninger inneholdende demInfo
- Publication number
- NO20031043D0 NO20031043D0 NO20031043A NO20031043A NO20031043D0 NO 20031043 D0 NO20031043 D0 NO 20031043D0 NO 20031043 A NO20031043 A NO 20031043A NO 20031043 A NO20031043 A NO 20031043A NO 20031043 D0 NO20031043 D0 NO 20031043D0
- Authority
- NO
- Norway
- Prior art keywords
- sub
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0011779A FR2814165B1 (fr) | 2000-09-15 | 2000-09-15 | Nouveaux derives biphenyles substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2001/002297 WO2002022555A1 (fr) | 2000-09-15 | 2001-07-16 | Derives biphenyles substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031043L NO20031043L (no) | 2003-03-06 |
| NO20031043D0 true NO20031043D0 (no) | 2003-03-06 |
Family
ID=8854338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031043A NO20031043D0 (no) | 2000-09-15 | 2003-03-06 | Nye substituerte bifenylforbindelser, fremgangsmåte for deres fremstillingog farmasöytiske sammensetninger inneholdende dem |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7161035B2 (no) |
| EP (1) | EP1317413B1 (no) |
| JP (1) | JP4015546B2 (no) |
| KR (1) | KR100580780B1 (no) |
| CN (1) | CN1233621C (no) |
| AT (1) | ATE302750T1 (no) |
| AU (2) | AU2001277595B2 (no) |
| BR (1) | BR0113907A (no) |
| CA (1) | CA2419934C (no) |
| DE (1) | DE60112951T2 (no) |
| DK (1) | DK1317413T3 (no) |
| EA (1) | EA005766B1 (no) |
| ES (1) | ES2248365T3 (no) |
| FR (1) | FR2814165B1 (no) |
| HU (1) | HUP0303349A3 (no) |
| MX (1) | MXPA03002018A (no) |
| NO (1) | NO20031043D0 (no) |
| NZ (1) | NZ524330A (no) |
| PL (1) | PL360574A1 (no) |
| PT (1) | PT1317413E (no) |
| SK (1) | SK4692003A3 (no) |
| WO (1) | WO2002022555A1 (no) |
| ZA (1) | ZA200301351B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005110410A2 (en) * | 2004-05-14 | 2005-11-24 | Abbott Laboratories | Kinase inhibitors as therapeutic agents |
| KR100626438B1 (ko) * | 2005-02-24 | 2006-09-21 | 웅진코웨이주식회사 | 산소발생기용 배관 모듈 |
| PT3095781T (pt) * | 2014-01-14 | 2018-11-16 | Astellas Pharma Inc | Composto de indol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5093352A (en) * | 1988-11-14 | 1992-03-03 | Whitby Research, Inc. | Antidepressant agents |
| ATE207460T1 (de) * | 1995-07-26 | 2001-11-15 | Takeda Chemical Industries Ltd | Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung |
| US5808151A (en) * | 1996-04-17 | 1998-09-15 | Bristol-Myers Squibb Company | Biphenylamido derivatives as melatonergic agents |
| FR2771739B1 (fr) * | 1997-11-28 | 2001-04-20 | Adir | Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2772766B1 (fr) * | 1997-12-24 | 2000-06-30 | Adir | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2784375B1 (fr) * | 1998-10-12 | 2000-11-24 | Adir | Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2000
- 2000-09-15 FR FR0011779A patent/FR2814165B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-16 ES ES01955425T patent/ES2248365T3/es not_active Expired - Lifetime
- 2001-07-16 BR BR0113907-0A patent/BR0113907A/pt not_active IP Right Cessation
- 2001-07-16 PT PT01955425T patent/PT1317413E/pt unknown
- 2001-07-16 DE DE60112951T patent/DE60112951T2/de not_active Expired - Fee Related
- 2001-07-16 MX MXPA03002018A patent/MXPA03002018A/es active IP Right Grant
- 2001-07-16 DK DK01955425T patent/DK1317413T3/da active
- 2001-07-16 AU AU2001277595A patent/AU2001277595B2/en not_active Ceased
- 2001-07-16 HU HU0303349A patent/HUP0303349A3/hu unknown
- 2001-07-16 EA EA200300376A patent/EA005766B1/ru not_active IP Right Cessation
- 2001-07-16 AU AU7759501A patent/AU7759501A/xx active Pending
- 2001-07-16 CN CNB018156428A patent/CN1233621C/zh not_active Expired - Fee Related
- 2001-07-16 AT AT01955425T patent/ATE302750T1/de not_active IP Right Cessation
- 2001-07-16 CA CA002419934A patent/CA2419934C/fr not_active Expired - Fee Related
- 2001-07-16 US US10/380,866 patent/US7161035B2/en not_active Expired - Fee Related
- 2001-07-16 EP EP01955425A patent/EP1317413B1/fr not_active Expired - Lifetime
- 2001-07-16 WO PCT/FR2001/002297 patent/WO2002022555A1/fr not_active Ceased
- 2001-07-16 SK SK469-2003A patent/SK4692003A3/sk unknown
- 2001-07-16 PL PL36057401A patent/PL360574A1/xx unknown
- 2001-07-16 KR KR1020037003773A patent/KR100580780B1/ko not_active Expired - Fee Related
- 2001-07-16 JP JP2002526756A patent/JP4015546B2/ja not_active Expired - Fee Related
- 2001-07-16 NZ NZ52433001A patent/NZ524330A/xx unknown
-
2003
- 2003-02-19 ZA ZA200301351A patent/ZA200301351B/en unknown
- 2003-03-06 NO NO20031043A patent/NO20031043D0/no not_active Application Discontinuation
-
2006
- 2006-12-18 US US11/640,595 patent/US20070123529A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005715D0 (no) | Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK1249461T3 (da) | Syreblokerede aminkatalysatorer til fremstilling af polyurethaner | |
| ATE372316T1 (de) | Multifunktionelle photoinitiatoren | |
| AR024969A1 (es) | Derivados de 8-fenil-6,9-dihidro-[1,2,4]triazol[3,4-i]purin-5-ona | |
| ATE334654T1 (de) | Vor uv-strahlen schützende zusammensetzungen | |
| ATE390950T1 (de) | Uv absorbierende zusammensetzung enthaltend hydroxyphenyltriazinverbindungen | |
| ATE517663T1 (de) | Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen | |
| EP1775289A4 (en) | NEW IMIDAZOLIDINE DERIVATIVES | |
| GB2378950A (en) | Stabilizer mixtures | |
| EA200000431A3 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| NO20031043L (no) | Nye substituerte bifenylforbindelser, fremgangsmåte for deres fremstillingog farmasöytiske sammensetninger inneholdende dem | |
| EP0335979A4 (en) | Thienopyrimidine derivatives | |
| DK1272480T3 (da) | Fremgangsmåde til fremstilling af spirocycliske tetronsyrederivater | |
| DE60237323D1 (de) | Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend | |
| WO2001079170A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
| ATE302209T1 (de) | Tetraphenylbacteriochlorin-derivate und diese enthaltenden zusammensetzungen | |
| NO20001541L (no) | Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| NO20003604L (no) | Nye tricykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| DE50006192D1 (de) | Mischungen aus phosphanen und chroman-derivaten | |
| NO20003431L (no) | Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DE60221250D1 (de) | Bis(5-aryl-2-pyridyl)derivate | |
| TR200402493T4 (tr) | Yeni 2,3-benzodiazepin türevleri ve aktif bileşen olarak bunları içeren farmasötik bileşimler. | |
| TW200502227A (en) | Novel lactone compound | |
| DE69828037D1 (de) | Pyrroloindol-derivate und zwischenprodukte zu ihrer herstellung | |
| TW200704669A (en) | Polymer compound and process for producing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |